Advanced search
Start date

Synthesis and pharmacological evaluation of Bromodomain inhibitors (BRD-3) designed as fetal hemoglobin inducers

Grant number: 16/08880-8
Support Opportunities:Scholarships in Brazil - Master
Effective date (Start): March 01, 2017
Effective date (End): February 28, 2018
Field of knowledge:Health Sciences - Pharmacy
Acordo de Cooperação: Coordination of Improvement of Higher Education Personnel (CAPES)
Principal Investigator:Jean Leandro dos Santos
Grantee:Gabriel Dalio Bernardes da Silva
Host Institution: Faculdade de Ciências Farmacêuticas (FCFAR). Universidade Estadual Paulista (UNESP). Campus de Araraquara. Araraquara , SP, Brazil


Sickle cell anemia (SCA) is one of the most prevalent genetic blood diseases in the world. Currently, therapeutic strategies aiming to increase the levels of fetal hemoglobin (HbF) contribute significantly in reducing morbidity and mortality associated with the disease. The comprehension of the molecular mechanisms involved in fetal hemoglobin gene silencing may allow the development of drugs able to induce HbF more effective and safe. During erythropoiesis, the gamma-globin gene expression is silenced, in part, by the binding of a complex containing the protein GATA-1, which binds at sites near to the promoter of gamma-globin gene preventing transcription. Specifically, GATA-1 recruitment is accomplished by bromodomain-3 (BRD-3). In this project, our hypothesis is that the inhibition of BRD-3 may be a new therapeutic approach capable of promoting HbF levels increasing. Therefore, we conducted a preliminary study of virtual screening with 2.2 million of molecules in order to identify some prototypes with potential inhibition of bromodomain-3 (BRD-3). From these, and by using tools of molecular modification, we propose herein the synthesis and pharmacological evaluation of a series of phthalimide derivatives as BRD-3 inhibitors (I) useful to treat the symptoms of sickle cell disease. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
SANTOS FERNANDES, GUILHERME FELIPE; BERNARDES SILVA, GABRIEL DALIO; PAVAN, ALINE RENATA; CHIBA, DIEGO EIDY; CHIN, CHUNG MAN; DOS SANTOS, JEAN LEANDRO. Epigenetic Regulatory Mechanisms Induced by Resveratrol. NUTRIENTS, v. 9, n. 11, . (15/19531-1, 16/08470-4, 16/08880-8, 16/09502-7)
DUTRA, LUIZ ANTONIO; HEIDENREICH, DAVID; BERNARDES DA SILVA, GABRIEL DALIO; CHIN, CHUNG MAN; KNAPP, STEFAN; DOS SANTOS, JEAN LEANDRO. Dietary Compound Resveratrol Is a Pan-BET Bromodomain Inhibitor. NUTRIENTS, v. 9, n. 11, . (15/19531-1, 16/08880-8, 14/03945-9)
Academic Publications
(References retrieved automatically from State of São Paulo Research Institutions)
SILVA, Gabriel Dalio Bernardes da. Planejamento, síntese e avaliação farmacológica de inibidores de bromodomínio-3 indutores de hemoglobina fetal. 2018. Master's Dissertation - Universidade Estadual Paulista (Unesp). Faculdade de Ciências Farmacêuticas. Araraquara Araraquara.

Please report errors in scientific publications list by writing to: